Malignant Esophageal Neoplasm — Trials

Malignant Esophageal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 518
Recruiting: 302
Ph III recruiting: 41
Growth YoY: +2.4%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.5%
Trials / 1,000 deaths: 32.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 101–102 of 102 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04172753	Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac	recruiting	N/A	472	University Hospital TuebingenOTHER	1	Nov 21, 2019	clinicaltrials
NCT01688908	Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)(ESECC)	active not recruiting	N/A	33,948	Peking UniversityOTHER	1	Jan 23, 2018	clinicaltrials